GSTO2 and diabetic kidney disease: Namely, we observed that individuals with the GSTO2*AG genotype were 2.6-fold more prone for symptomatic diabetic nephropathy development (OR = 2.59, 95%CI = 1.11–6.05, p = 0.028) in comparison to the carriers of the wild-type GSTO2*AA genotype.